More than 80% of Texans are in favor of medical cannabis, while a smaller majority backs recreational pot, according to a new survey.

The poll, which comes via the Hobby School of Public Affairs at the University of Houston, found that 82% of Texans support legalizing marijuana for medicinal use. Sixty-seven percent of Texans support legislation that would make the recreational use of marijuana for any purpose legal for those age 21 and older, according to the poll.

“Attitudes about the use of marijuana have been evolving over the past few decades, and we found especially strong support for expanding the use of medical marijuana,” said Renée Cross, senior executive director and researcher at the Hobby School, as quoted by Houston Public Media. “But a majority of Texans across-the-board – across partisan, generational and racial and ethnic lines – also said they support legalization for recreational use.”

Medical cannabis is legal in the Lone Star State, but the law is highly restrictive. Qualifying patients are only allowed cannabis products that contain 1% THC or less. The program is also plagued by a dearth of dispensaries, with only three new licenses issued in the past three years.

Last month, the Texas Department of Public Safety said that it was trying to mitigate that as it began accepting applications for new dispensary licenses. 

“An announcement detailing the process for application acceptance and the subsequent approval process to issue additional licenses will be made at a later date. The department will issue only the number of licenses necessary to ensure reasonable statewide access to, and the availability of, low-THC cannabis for patients registered in the compassionate-use registry,” the department said in its announcement last month.

Recreational marijuana, meanwhile, remains prohibited. 

The polling data from the University of Houston shows strong support across multiple demographics for both. 

Among the 82% who say they support medical cannabis, 56% said they are “strongly” in favor of the policy. 

Here’s more from the cross-tabs:

“85% of Latino, 83% of Black and 80% of white Texans support this [medical cannabis] legislation. This includes 60% of Latinos and 55% of whites who strongly support it. 83% of women and 80% of men support this legislation. 93% of Democrats, 79% of Independents and 73% of Republicans support this legislation. This includes 71% of Democrats who strongly support it.”

As for recreational pot, 47% said they are “strongly” in favor. 

“When asked about preferences regarding the sale and use of marijuana in Texas, 54% of Texans opt for legislation under which marijuana would be legal for medical and recreational use and 28% of Texans opt for legislation under which marijuana would be legal for medical use only. Finally, 18% of Texans prefer the current legislative status quo under which marijuana use for either recreational or medical purposes is illegal in Texas,” the pollsters wrote. 

Mark P. Jones, senior research fellow at the Hobby School and political science fellow at Rice University’s Baker Institute for Public Policy, observed some partisan and religious division in the polling numbers.

“A significant minority of Texans, especially those who identify as Republican, Independent and born-again Christian, say they personally do not favor easing state regulations,” Jones said, as quoted by Houston Public Media.  “Almost one out of five Texans, or 18%, said they would prefer no change to the state’s current marijuana laws.”

Cross, meanwhile, envisions reform for the state’s medical cannabis law.

“If anything, I think we’ll see the diseases or illnesses allowed probably expanded,” she said, as quoted by Houston Public Media. “So in essence, it will make it easier to get a prescription for medical marijuana in Texas.”

The post More Than 80% of Texans Back Medical Cannabis, Poll Says appeared first on High Times.

The post More Than 80% of Texans Back Medical Cannabis, Poll Says appeared first on Paradise Found.

Could a fentanyl vaccine potentially save thousands of lives? A recent animal study published in the journal Pharmaceutics indicates that a fentanyl vaccine was able to block the drug from entering the brain of rats—thus making it a worthy candidate for human studies and eventually something available to the public that can save lives.

Researchers administered rats with three doses of the vaccine or immunization at three-week intervals, and another group of rats received a placebo. To determine if the drug was working, they tested the immunized rats’ pain responses by heating up their tails for up to 10 seconds and seeing how long they took to pull away.

The vaccination significantly reduced entry of fentanyl into the brain and anti-fentanyl antibodies targeted fentanyl with no cross-reactions to other opioids. 

“We believe these findings could have a significant impact on a very serious problem plaguing society for years—opioid misuse,” study lead author Colin Haile told University of Houston (UH) news. “Our vaccine is able to generate anti-fentanyl antibodies that bind to the consumed fentanyl and prevent it from entering the brain, allowing it to be eliminated out of the body via the kidneys. Thus, the individual will not feel the euphoric effects and can ‘get back on the wagon’ to sobriety.” 

Haile is a research associate professor of psychology at UH and the Texas Institute for Measurement, Evaluation and Statistics (TIMES), and a founding member of the UH Drug Discovery Institute.  

“The anti-fentanyl antibodies were specific to fentanyl and a fentanyl derivative and did not cross-react with other opioids, such as morphine. That means a vaccinated person would still be able to be treated for pain relief with other opioids,” said Haile. 

Meanwhile, over 150 people die every day of overdose from synthetic opioids including fentanyl, which is 50 times stronger than heroin and 100 times stronger than morphine. Just 2 milligrams of fentanyl, or the size of two grains of rice, can be fatal depending on the size of the person.  

“These preclinical results demonstrate efficacy in neutralizing [fentanyl]’s effects and warrant further development as a potential therapeutic for OUD and overdose in humans,” researchers wrote in the study. “We expect minimal side effects in clinical trials because the two components of our formulation (CRM and dmLT) are already in other vaccines on the market or have been tested in multiple human clinical trials and shown to be safe and effective. Further, the effective dose of dmLT used in human clinical trials is comparable to the dose used in the present study. Since low vaccine concentrations elicit adequate anti-[fentanyl] antibody levels, we expect there to be no adverse events when this vaccine is tested in humans.”

The vaccine did not lead to any adverse side effects in the immunized rats that were observed. 

Researchers plan to begin manufacturing a clinical-grade vaccine in the coming months with clinical trials on humans planned soon.  

Efforts are being made to abate the deadly toll fentanyl plays on America. The U.S. Drug Enforcement Administration (DEA) announced the results of a widespread drug operation last September, with data spanning May to September, resulting in over 10 million fentanyl pills and what they say is 36 million lethal doses of the drug.

The DEA says that fentanyl is the deadliest drug threat facing this nation. “In 2021, a record number of Americans—107,622—died from a drug poisoning or overdose,” the DEA release reads. “Sixty-six percent of those deaths can be attributed to synthetic opioids such as fentanyl.”

The post Fentanyl Vaccine Called ‘Game-Changer’ appeared first on High Times.

The post Fentanyl Vaccine Called ‘Game-Changer’ appeared first on Paradise Found.